Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-3.11%)
As of: Sep 30, 2026 · 1:32 PM EDT

Metagenomi Therapeutics, Inc. (MGX) Receivables - Accured (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) reported Receivables - Accured of $900,000 for Q2 2026, down 35.7% from $1.4 million a year earlier and down 10.0% from the prior quarter.

Analysis

Metagenomi Therapeutics, Inc. (MGX) Receivables - Accured (2023 - 2026) Analysis & Trends

At the end of FY2025, Metagenomi Therapeutics posted Receivables - Accured of $1.2 million, down 25.0% from FY2024.

  • By year, Receivables - Accured came in at $1.6 million in FY2024 (+60.0%) and $1 million in FY2023.
  • The Q2 2026 figure ranks as the lowest quarterly Receivables - Accured in data going back to Q4 2023.
  • Year over year, Receivables - Accured has now declined in each of the last four quarters, with an average decline of 4.8% over the last seven quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1 million (Q1 2026), $1.2 million (Q4 2025) and $1.3 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 900,000.00
Mar 31, 2026 1.00 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.30 Mn
Jun 30, 2025 1.40 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 1.60 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 1.40 Mn
Mar 31, 2024 1.30 Mn
Dec 31, 2023 1.00 Mn
API Access

Metagenomi Therapeutics, Inc. Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=MGX&period=max&api_key=YOUR_API_KEY